Company profile for Nanomerics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nanomerics develops precision medicines that address medical need by focusing on reducing the typical development costs, resources and timelines. Nanomerics' proprietary technology addresses medical and non-medical applications with a focus on conditions at the front and back of the eye, CNS conditions and challenging oral active pharmaceutical ingredients (APIs). Nanomerics has a pipeline of its own as well as partnere...
Nanomerics develops precision medicines that address medical need by focusing on reducing the typical development costs, resources and timelines. Nanomerics' proprietary technology addresses medical and non-medical applications with a focus on conditions at the front and back of the eye, CNS conditions and challenging oral active pharmaceutical ingredients (APIs). Nanomerics has a pipeline of its own as well as partnered programs addressing important areas of medical need and orphan indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Block Y, Northwick Park and St Mark's Hospital, Watford Road, Harrow, London H...
Telephone
Telephone
+44 20 3397 2183
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/nanomerics-reports-last-volunteer-visit-in-the-oc134-sunlight-trial-th-996230

ACCESSWIRE
10 Mar 2025

https://www.accesswire.com/966003/nanomerics-reports-complete-dosing-of-the-last-volunteer-in-the-oc134-sunlight-trial

ACCESSWIRE
09 Jan 2025

https://www.quotientsciences.com/news/nanomerics-reports-complete-dosing-last-volunteer-oc134-sunlight-trial

PRESS RELEASE
01 Jan 2025

https://www.quotientsciences.com/news/quotient-sciences-and-nanomerics-dose-first-volunteers-oc134-sunlight-trial

PRESS RELEASE
11 Dec 2024

https://www.accesswire.com/942889/uk-regulator-mhra-grants-nanomerics-clinical-trials-authorisation-notice-for-its-upcoming-oc134-clinical-trial

ACCESSWIRE
18 Nov 2024

https://www.accesswire.com/859819/nanomerics-wins-the-united-kingdom-kings-award-for-enterprise-innovation-2024

ACCESSWIRE
06 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty